The Chief Executive Officer, President, and co-founder of Alector, Inc. is Dr. Arnon Rosenthal, who has led the clinical-stage biotechnology enterprise since its inception. A veteran scientist and biotechnology entrepreneur, he previously co-founded Rinat Neuroscience and Annexon Biosciences. Under his executive leadership, the company focuses heavily on advancing innovative immuno-neurology platforms and antibody treatments designed to combat complex neurodegenerative disorders like Alzheimer's disease and frontotemporal dementia.